US FDA Cast As Culpable Player In Opioid Epidemic In Hulu’s Dopesick Series
Executive Summary
Show depicts former agency officials approving OxyContin labeling that enabled Purdue to market it as nonaddictive and subsequently refusing pleas to restrict its use.
You may also be interested in...
Opioid Abuse Groups Criticize US FDA For Using Purdue Pharma-Connected Data Firm
The advocates say the Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS) and its Substance Abuse Treatment Center Programs Combined Survey has conflicts of interest, as well as a connection to the infamous maker of OxyContin.
Opioid Jury Verdict May Change Settlement Equation For Sponsors
New York jury finds that Teva and distributor Anda violated state’s public nuisance law in their marketing and distribution of opioids. Such claims had been rejected by two previous courts and the verdict in this case shows the challenges companies face in ongoing litigation.
Selling Opioids Is Not A Public Nuisance For Three Reasons, Oklahoma State Appeals Court Rules
Overturning a $465m verdict against J&J, Oklahoma Supreme Court rejects claim opioid sales violated a public right. It says a manufacturer does not have control of its product once it is sold and cannot be held perpetually liable for its products.